{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2021/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Michael John Munchhof", "item": "https://www.patentleaderboard.com/2021/inventor/fl:mi_ln:munchhof-1"}]}

Home › 2021 › Pfizer › Michael John Munchhof

Michael John Munchhof — 1 Patent in 2021

EPEpizyme: 1 patents #7 of 24Top 30%

Salem, CT: #5 of 9 inventorsTop 60%

Connecticut: #1,399 of 4,045 inventorsTop 35%

Overall (2021): #330,186 of 548,734Top 65%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10980794	PRMT5 inhibitors and uses thereof	Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin	2021-04-20	$11,349,000

Michael John Munchhof — 1 Patent in 2021

Issued Patents 2021

Patent Widget